TrialAlzheimer's & dementia : the journal of the Alzheimer's Association2025

Long-term safety and efficacy of lecanemab in early Alzheimer's disease: Results from the clarity AD open-label extension study.

Christopher H van Dyck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.